Category: Women’s health · Menopause · Hormone therapy · Breast health
Hot Flashes Returning Years After Hysterectomy: Why Hormones Still Swing, Adjusting Estrogen Dose, Mammogram Follow-Up for a Breast Lump, and Safe Morning Exercise
AI Overview / Quick Answer (BLUF)
Removing the uterus but keeping the ovaries leaves them working and ageing, so hormones swing and hot flashes return around 50, often for about 7 years. Estrogen alone is used without a uterus; transdermal carries less clot risk than oral. Breast lumps still need scheduled imaging.
the ovaries after hysterectomy,
estrogen alone in the WHI trial,
mammograms while on hormones
and exercise. Background on hot flashes from the NIA
and mammograms from the NCI.
Red flags ·
Why symptoms return ·
Estrogen therapy ·
Mammograms with a lump ·
Morning exercise ·
Comparison table ·
FAQ
From a menopause support group: hysterectomy years ago, hot flashes are back, and a breast lump is being followed
A member around 50 shared that she had a hysterectomy several years ago with her ovaries kept, yet hot flashes return in waves every year.
She is on hormone therapy, her doctor recently raised the dose, she has a follow-up mammogram for a breast lump,
and she gets up before dawn to hula hoop, lift weights and stretch every day. Others in the group asked why symptoms happen without a uterus,
whether a higher hormone dose is risky for the breast, and how much exercise helps.
The short answer: retained ovaries keep working and still age, so recurring symptoms are common.
Hormone therapy is a personal balance of benefit and risk, a breast lump must be followed on your doctor’s schedule, and exercise is a supporting tool.
If insomnia started in the first months after surgery, see Hysterectomy with ovaries kept: hot flashes and insomnia.
Red flags — seek medical care promptly
Direct answer: oral estrogen slightly raises the risk of clots and stroke, and a breast lump that changes needs prompt assessment
(Anderson 2004,
Vinogradova 2019)
Go to hospital now or call emergency services (1669 in Thailand)
- Swelling, pain, redness or warmth in one leg — possible deep vein clot
- Chest pain, sudden breathlessness or coughing blood — possible clot in the lungs
- Facial droop, one-sided weakness, slurred speech, sudden loss of vision or a sudden severe headache — possible stroke; every minute counts
See a doctor within 1 to 2 weeks
- A new lump, or a known lump that grows quickly, feels hard and does not move, even if you had a recent mammogram
- Dimpled, puckered or orange-peel breast skin, or a newly inverted nipple
- Clear or bloody discharge from one nipple without squeezing, or a lump in the armpit
- Any vaginal bleeding — it should not happen after a hysterectomy and needs checking
- Night sweats with fever, unintended weight loss, or a racing heart and tremor — may not be menopause, for example an overactive thyroid or infection
1. Why hot flashes come back in waves after a hysterectomy
Direct answer: the uterus does not make hormones; the ovaries make estrogen. When the ovaries are kept, they keep working and still age.
Around 45 to 55, estrogen rises and falls before it drops for good, but there are no periods to show that this phase has started
(Moorman 2011,
Avis 2015).
The ovaries may decline a little earlier after hysterectomy
A study of women aged 30 to 47 compared 406 who had a hysterectomy with 465 who did not. The hysterectomy group reached ovarian failure sooner
(HR 1.92): 14.8% versus 8.0% within 4 years, and even with both ovaries kept the onset was earlier (HR 1.74).
The authors could not tell whether the surgery itself or the condition that led to surgery was responsible
(Moorman 2011).
Bar lengths are scaled for comparison; actual values are shown in the bars (Moorman 2011).
Hot flashes last longer than many people expect
The SWAN study followed 1,449 women and found that frequent hot flashes lasted a median of about 7.4 years and persisted about 4.5 years after the final period.
Waves of symptoms at 50 therefore match the natural transition of the ovaries
(Avis 2015).
has not been shown in that form. What the data show is a higher chance of earlier ovarian failure (HR 1.74 to 1.92), with the cause still unclear.
Other causes to rule out
- An overactive thyroid (racing heart, weight loss, tremor)
- Some medicines, such as certain antidepressants, anti-hormone breast cancer drugs, or glucose-lowering drugs that cause low blood sugar
- Infection with fever, alcohol, coffee, spicy food, hot rooms and stress, which act as triggers
2. Estrogen therapy after hysterectomy: benefits, risks and dose adjustment
Direct answer: without a uterus, doctors usually prescribe estrogen alone, with no progestogen. But estrogen alone is not risk-free;
the risk depends on the type, dose, route, age and time since menopause
(NAMS 2022).
Why no progestogen is needed
A progestogen protects the womb lining from thickening under estrogen, so it is not needed once the uterus is removed.
The exception is past endometriosis, where a doctor may add a progestogen to lower the chance that remaining lesions flare.
What the WHI estrogen-alone trial found
10,739 women aged 50 to 79 after hysterectomy took oral conjugated estrogens 0.625 mg a day or placebo for an average of 6.8 years.
Stroke rose (HR 1.39, or 12 extra cases per 10,000 women per year), hip fracture fell (HR 0.61),
coronary heart disease did not rise (HR 0.91), and breast cancer did not increase (HR 0.77)
(Anderson 2004).
Long-term follow-up: breast cancer and mortality
After more than 20 years, the estrogen-alone group had fewer breast cancers than placebo (238 vs 296 cases, HR 0.78)
and fewer breast cancer deaths (30 vs 46, HR 0.60), whereas combined estrogen plus progestin increased breast cancer (HR 1.28).
Death from any cause over 18 years did not differ from placebo (HR 0.94)
(Chlebowski 2020,
Manson 2017).
These results come from one drug in one trial, so they do not show that estrogen prevents breast cancer.
Skin versus tablet: clot risk differs
UK database studies covering 80,396 venous clot cases found that oral estrogen alone raised clot risk (OR 1.40),
oral combined therapy raised it more (OR 1.58), and transdermal gels or patches were not associated with higher risk (OR 0.93).
Oral estradiol carried less risk than conjugated estrogens (OR 0.85)
(Vinogradova 2019).
OR 1.0 = same as women not using hormones (Vinogradova 2019).
Dose adjustment: why some women need more
As the ovaries make less estrogen with age, the old dose may stop controlling symptoms, so the doctor adjusts it to find the lowest dose that works.
With skin gels, absorption depends on the area covered, the site, and washing or sweating after application, so follow your doctor’s or pharmacist’s instructions.
Do not raise or lower your hormone dose on your own. NAMS 2022 advises periodic review of benefits and risks;
for women under 60 or within 10 years of menopause without contraindications, benefits usually outweigh risks when treating bothersome hot flashes
(NAMS 2022).
If hormones are stopped abruptly
In the WHI combined-hormone trial, after stopping, 55.5% of women who had symptoms at baseline reported moderate to severe hot flashes again,
versus 21.3% on placebo. Plan any reduction or stop with your doctor
(Ockene 2005).
Table: hormone options after hysterectomy
Generic names only. The type and dose are chosen by your own doctor.
| Type | Suits | Clot risk | Key points |
|---|---|---|---|
| Estradiol gel or skin patch | Women with clot risk, excess weight or high blood lipids | No clear increase (OR 0.93) | Apply to the recommended site, wash hands afterwards, avoid skin contact with others |
| Oral estradiol | Women who prefer tablets and have no clot risk | Slight increase, lower than conjugated estrogens | Passes through the liver first, raising clotting factor production |
| Oral conjugated estrogens | The type used in the WHI trial | Increased; stroke HR 1.39 | Long-term data on both bone benefit and stroke risk |
| Estrogen + progestogen | Women with a uterus, or past endometriosis | Higher when oral (OR 1.58) | Combined therapy raises breast cancer (HR 1.28); not needed for most women after hysterectomy |
| Low-dose vaginal estrogen | Vaginal dryness, painful sex, bladder irritability | No clear increase | Does not treat hot flashes; can be combined with other types as your doctor advises |
How severe are your hot flashes, sleep problems and mood swings?
Analyse the severity and get personalised guidance from our Advisory team. This score sorts menopause symptoms into mild, moderate,
or see-a-doctor-soon bands; it is not a diagnosis and does not replace breast checks. Use it together with the red-flag list above.
3. A breast lump while on hormones: how it is checked and how often
Direct answer: an unexplained lump must be worked up first, whether or not you use hormones.
The follow-up interval depends on the imaging and biopsy results, not on a single number for everyone
(USPSTF 2024,
Hartmann 2005).
Steps after finding a lump
Doctors usually order a diagnostic mammogram, which takes more views than a screening one, together with ultrasound to tell a cyst from a solid mass.
If the images remain unclear, a needle biopsy shows the cell type. The result is reported as a BI-RADS category that sets the next step.
Different benign lesions carry different risks
A study of 9,087 women with benign breast disease, followed for a median of 15 years, found a slightly higher overall breast cancer risk (RR 1.56),
depending on cell type: nonproliferative lesions, 67% of cases, carried a small increase (RR 1.27) and no increase without a family history;
proliferative lesions without atypia carried RR 1.88; and lesions with atypia, only 4% of cases, carried a higher risk (RR 4.24)
(Hartmann 2005).
RR 1.0 = same as women in the general population (Hartmann 2005).
Does estrogen make mammograms harder to read?
In the WHI, the estrogen-alone group had more short-interval follow-up mammograms (39.2% vs 29.6%) and more biopsies (12.5% vs 10.7%),
but abnormal mammograms were no more frequent (7.3% vs 7.0%) and cancer detection was not clearly compromised.
Over 5 years, about 1 in 11 women had an extra short-interval recall and about 1 in 50 an extra biopsy
(Chlebowski 2010).
A recall does not mean cancer. Always tell the radiologist you are on hormones.
Screening and lump follow-up are different schedules
USPSTF 2024 recommends screening mammography every 2 years for average-risk women aged 40 to 74,
and finds the evidence insufficient to recommend extra ultrasound or MRI for everyone, even with dense breasts.
For a known lump, the interval follows the BI-RADS and biopsy result and may be shorter than the screening cycle
(USPSTF 2024).
Follow your doctor’s schedule based on the actual report.
Table: breast imaging results and next steps
BI-RADS is the shared language of radiologists; actual steps depend on your own doctor.
| Result | Meaning | Usual next step | Hormone therapy |
|---|---|---|---|
| BI-RADS 1 to 2 | Normal, or a benign finding such as a simple cyst | Return to routine screening | Usually continued as planned |
| BI-RADS 3 | Probably benign; cancer chance no more than about 2% | Short-interval repeat imaging, about 6 months | Discuss with your doctor; usually continued with follow-up |
| BI-RADS 4 to 5 | Suspicious; tissue diagnosis needed | Needle biopsy | Doctors often pause hormones until results are back |
| Biopsy shows atypia | Benign but higher risk (RR 4.24) | See a breast surgeon; may be removed with closer follow-up | Benefits and risks need re-review |
| New palpable lump, normal images | Some lumps are not seen on mammograms | Ultrasound and repeat examination | Tell your doctor; do not stop or raise the dose yourself |
4. Morning exercise: how much it helps hot flashes and how to do it safely
Direct answer: exercise can support treatment but does not replace medication. Resistance training has trial evidence for short-term relief of hot flashes,
while its clearer benefits are for bone, muscle, heart and some cancer risks
(Berin 2019,
Daley 2014).
Resistance training and hot flashes
A Swedish trial enrolled 58 postmenopausal women not on hormones, mean age 55, averaging 7.1 hot flashes a day.
Eight resistance exercises 3 times a week for 15 weeks cut moderate to severe hot flashes by 43.6% versus 2.0% in controls
(Berin 2019).
In follow-up, the effect was still seen at 6 months but not maintained at 2 years
(Nilsson 2024).
A small trial in women not on hormones; the added effect in women already on hormones is unknown (Berin 2019).
Limits of the evidence
A Cochrane review of 5 trials in 733 women found no clear difference between exercise and no treatment (SMD −0.10), with low-quality evidence.
NAMS 2023 therefore does not recommend exercise or yoga as a direct treatment for hot flashes,
and instead recommends CBT, clinical hypnosis and certain nonhormonal drugs for women who cannot use hormones
(Daley 2014,
NAMS 2023).
Clearer benefits: bone and muscle
The LIFTMOR trial had 101 postmenopausal women with low bone mass, mean age 65, do supervised resistance and impact training for 30 minutes twice a week for 8 months.
Lumbar spine bone density rose 2.9% while the control group lost 1.2%, and every physical function measure improved
(Watson 2018).
Training at that intensity should be supervised, especially with osteoporosis.
Exercise and breast cancer risk
The US Physical Activity Guidelines review found that women in the highest activity group, compared with the lowest, had about 10–20% lower risk of several cancers including breast cancer.
That lowers part of the risk; it does not prevent cancer, so breast checks on schedule still matter
(McTiernan 2019).
Reviewing the routine: hula hoop, weights and stretching
The WHO recommends 150 to 300 minutes of moderate aerobic activity a week plus regular muscle strengthening on at least 2 days a week
(Bull 2020).
Hula hooping 30 minutes on most days equals about 210 minutes of aerobic activity a week, 15 minutes of weights counts as strengthening, and stretching helps joints and balance,
so the routine already sits in the recommended range. What can be added: focus on leg, hip and back exercises that load bone, and increase weight gradually.
Precautions for pre-dawn exercise
- There is no evidence that pre-dawn is better than other times; consistency matters more than timing
- Warm up for 5 to 10 minutes before lifting, and drink water after waking
- Wear breathable clothing and use a fan, since body heat can trigger hot flashes
- An overly heavy weighted hoop can bruise the abdomen or strain the back; choose one you can spin comfortably
- Start weights at 2 to 3 sets of 8 to 12 repetitions; do not hold your breath, breathe out on effort, especially with high blood pressure
- Stop at once for chest tightness, faintness, an unusual racing heart or breathlessness
5. Comparing options for hot flashes
Direct answer: hormone therapy remains the most effective treatment for hot flashes.
For women who cannot or prefer not to use hormones, there are nonhormonal drugs and therapies with evidence
(NAMS 2022,
NAMS 2023).
Table: comparing drugs, therapies and exercise for hot flashes
Generic names only; use only as planned by your own doctor.
| Option | Effect on hot flashes | Evidence | Cautions |
|---|---|---|---|
| Estrogen (transdermal or oral estradiol) | Clear reduction | High (NAMS 2022) | Not for women with past breast cancer, clots or stroke |
| SSRI / SNRI (paroxetine, escitalopram, venlafaxine) | Moderate reduction | High (NAMS 2023) | Nausea, insomnia; some interact with other drugs |
| Gabapentin | Moderate reduction; helps night sweats | High (NAMS 2023) | Drowsiness, dizziness; often taken at bedtime |
| Fezolinetant | Reduction, acting on the brain’s temperature centre | High (NAMS 2023) | Liver tests as scheduled |
| CBT and clinical hypnosis | Less bother from symptoms; better sleep | High (NAMS 2023) | Takes several weeks |
| Resistance training (weights) | 43.6% reduction in a small trial; effect not lasting | Limited (Berin 2019) | Increase weight gradually; protect the back |
| Aerobic (hula hoop, brisk walking) | Unclear | Low (Daley 2014) | Good for heart, weight and mood |
| Stretching, yoga | Unclear | Not recommended as a direct treatment (NAMS 2023) | Helps joints, balance and stress |
Beliefs worth correcting
Without a uterus, you should not get menopause symptoms
Not true. The retained ovaries keep working and still age, so menopause symptoms happen as usual; there are just no periods to signal them.
Needing a higher dose means your body is getting worse
Not necessarily. It usually reflects the ovaries making less hormone with age, so the doctor adjusts to the lowest dose that controls symptoms.
Estrogen alone carries no vascular risk
Not true. Estrogen alone is not risk-free: oral forms slightly raise stroke and clot risk, while transdermal forms raise clot risk less.
Regular mammograms mean you will not get cancer
Not true. A mammogram finds cancer earlier but does not prevent it, and some lumps cannot be seen on mammograms, so always report a new palpable lump.
A breast lump means stopping hormones immediately
It depends on the result. Most benign lumps allow hormones to continue with follow-up, but while awaiting a biopsy or after a suspicious result, doctors may pause them.
Enough exercise lets you quit hormones
Exercise can support treatment but does not replace medication. Its effect on hot flashes is limited, and any reduction or stop should be planned with your doctor.
Frequently asked questions (FAQ)
My hysterectomy was years ago. Why do hot flashes keep coming back every year?
If only the uterus was removed and the ovaries were kept, the retained ovaries keep working and still age. As you approach 50 they go through the same transition as in any woman, so estrogen rises and falls and hot flashes come in waves, but there are no periods to signal it. A study of women aged 30 to 47 found that those who had a hysterectomy reached ovarian failure sooner than a comparison group (HR 1.92), and hot flashes overall last a median of about 7.4 years. Recurring episodes are therefore common, but tell your doctor so other causes such as thyroid disease, medicines or infection can be ruled out.
I am already on hormones, but symptoms returned and my doctor raised the dose. What does that mean?
It usually means the ovaries are making less estrogen with age, so the old dose no longer controls symptoms. Your doctor adjusts the dose to find the lowest one that works; it does not mean your condition is getting worse. With a skin gel, absorption also depends on where and how widely you apply it and whether the skin is washed afterwards, so follow the instructions from your doctor or pharmacist. Do not raise or lower your hormone dose on your own, and review symptoms with your doctor about 2 to 3 months after a change.
Without a uterus, how safe is estrogen alone?
Estrogen alone is not risk-free, but without a uterus no progestogen is needed to protect the womb lining, except in women with past endometriosis. In the WHI trial of 10,739 women after hysterectomy given oral conjugated estrogens 0.625 mg a day, stroke rose (HR 1.39, or 12 extra cases per 10,000 women per year) while hip fracture fell (HR 0.61). UK data found oral estrogen raised the risk of venous clots (OR 1.40) whereas transdermal estrogen did not (OR 0.93). The NAMS 2022 statement says that for women under 60 or within 10 years of menopause without contraindications, benefits outweigh risks when treating bothersome hot flashes.
I have a breast lump. Can I use hormones, and how often do I need a mammogram?
A lump that has not been explained must be worked up first, with a diagnostic mammogram plus ultrasound, and a needle biopsy when the images are unclear. If it is confirmed benign, doctors often continue hormones with follow-up. The interval depends on the BI-RADS result; a probably benign finding is usually rechecked in about 6 months, while a normal result usually returns to routine screening. USPSTF 2024 recommends screening mammography every 2 years for average-risk women aged 40 to 74. There is no evidence that everyone needs a mammogram plus ultrasound every year. A biopsy showing atypia carries higher risk, so discuss continuing hormones with your doctor.
Do hormones make mammograms harder to read?
They can lead to slightly more repeat imaging. In the WHI, women on estrogen alone had more short-interval follow-up mammograms than placebo (39.2% vs 29.6%) and more biopsies (12.5% vs 10.7%), but abnormal mammograms were no more frequent (7.3% vs 7.0%) and cancer detection was not clearly compromised. Combined estrogen plus progestin makes breast tissue denser than estrogen alone. Always tell the radiologist that you are on hormones.
Do exercise, hula hooping and weight training really reduce hot flashes?
They help a little but do not replace medication. A Swedish trial of 58 postmenopausal women not on hormones found that resistance training 3 times a week for 15 weeks cut moderate to severe hot flashes by 43.6% versus 2.0% in controls, but a 2-year follow-up showed the effect did not last. A Cochrane review of 733 women found no clear benefit of exercise overall on hot flashes. Exercise can support treatment but does not replace medication; its clearer benefits are for bone, muscle, heart, mood and sleep.
I get up at 5 a.m. to exercise every day. What should I watch out for?
There is no evidence that early-morning exercise is better than other times; consistency matters most. The WHO recommends 150 to 300 minutes of moderate aerobic activity a week plus muscle strengthening on at least 2 days a week, so 30 minutes of hula hooping, 15 minutes of weights and stretching already fall within that range. Warm up for 5 to 10 minutes, drink water, wear breathable clothing, avoid an overly heavy weighted hoop that can bruise the abdomen or strain the back, add weight gradually, and stop at once for chest tightness, faintness or breathlessness.
Which symptoms on hormone therapy need urgent care?
Go to hospital or call emergency services for one-sided leg swelling or pain, sudden chest pain or breathlessness, facial droop, one-sided weakness, slurred speech or sudden loss of vision, because these can signal a clot or stroke. See a doctor within 1 to 2 weeks for a new lump or one that grows quickly, dimpled or puckered breast skin, a newly inverted nipple, bloody discharge from one nipple, a lump in the armpit, or any vaginal bleeding, which should not happen after a hysterectomy.
Scientific mechanism
Hot flashes start in the brain: in the hypothalamus, KNDy neurons release kisspeptin, neurokinin B and dynorphin.
Estrogen restrains these neurons. When estrogen falls or swings sharply, neurokinin B signalling increases and the body’s comfortable temperature range narrows,
so a small rise in core temperature triggers skin vessel dilation and sweating, which is a hot flash. Fezolinetant works by blocking the neurokinin 3 receptor at this point
(NAMS 2023).
Why skin estrogen carries less clot risk: oral estrogen is absorbed from the gut and reaches the liver first at high concentration,
so the liver makes more clotting factors and other proteins. Transdermal estrogen enters the bloodstream directly and affects the liver less
(Vinogradova 2019).
Estrogen alone versus combined therapy in the breast: the progestin in combined therapy stimulates breast cell division and makes tissue denser,
raising breast cancer and making mammograms harder to read. One hypothesis for why estrogen alone did not raise cancer in women years past menopause
is that estrogen-deprived cells may undergo programmed death when estrogen returns; this still needs proof
(Chlebowski 2020).
Load and impact build bone: bone responds to large, fast strains. Osteocytes sense bone deformation and signal new bone formation,
so sufficiently heavy resistance training can increase bone density, while light aerobic activity alone does not load bone enough
(Watson 2018).
Compiled and reviewed by Asst. Prof. Dr. Norawit Raatpiboon
Academic references (E-E-A-T)
- Moorman PG et al. Effect of hysterectomy with ovarian preservation on ovarian function. Obstet Gynecol 2011 (PMID 22067716)
- Avis NE et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015 (PMID 25686030)
- The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 2022 (PMID 35797481)
- The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause 2023 (PMID 37252752)
- Anderson GL et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 2004 (PMID 15082697)
- Manson JE et al. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials. JAMA 2017 (PMID 28898378)
- Chlebowski RT et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials. JAMA 2020 (PMID 32721007)
- Chlebowski RT et al. Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy. J Clin Oncol 2010 (PMID 20439627)
- Hartmann LC et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005 (PMID 16034008)
- Vinogradova Y et al. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 2019 (PMID 30626577)
- Ockene JK et al. Symptom experience after discontinuing use of estrogen plus progestin. JAMA 2005 (PMID 16014592)
- Daley A et al. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2014 (PMID 25431132)
- Berin E et al. Resistance training for hot flushes in postmenopausal women: A randomised controlled trial. Maturitas 2019 (PMID 31239119)
- Nilsson S et al. A 2-year follow-up to a randomized controlled trial on resistance training in postmenopausal women: vasomotor symptoms, quality of life and cardiovascular risk markers. BMC Womens Health 2024 (PMID 39272114)
- Watson SL et al. High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial. J Bone Miner Res 2018 (PMID 28975661)
- Bull FC et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med 2020 (PMID 33239350)
- McTiernan A et al. Physical Activity in Cancer Prevention and Survival: A Systematic Review. Med Sci Sports Exerc 2019 (PMID 31095082)
- US Preventive Services Task Force. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2024 (PMID 38687503)
- NIA — Hot Flashes: What Can I Do? · NCI — Mammograms
Medical disclaimer
This article provides general educational information about menopause symptoms after hysterectomy, estrogen therapy, breast checks and exercise. It is not a diagnosis, prescription or personal treatment plan.
Drug names are generic and for education only. Do not start, change or stop hormones without consulting your own doctor. Breast imaging and biopsy results are interpreted by your radiologist and treating doctor.
In an emergency, call your local emergency number (1669 in Thailand).